Confidential unit exclusion (cue): Impact on transfusion safety
Transfusion · 2026-08 · 66 (8) · 1475-1479
DOI: 10.1111/trf.70271 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transfusion, online erschienen am 16.05.2026. Verfasst von Rita Queirós Pereira und 6 weiteren Autor:innen. Beteiligte Einrichtung: Immunohemotherapy Department, São João Local Health Unit, Porto, Portugal. Hauptthemen laut MEDLINE: Blood Safety, Blood Donors, Blood Transfusion, Transfusion Reaction. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Confidential Unit Exclusion (CUE) was introduced when earlier‐generation assays had lower sensitivity and longer infectious window periods for transfusion‐transmitted infections. Improvements in serological and molecular testing have raised questions about its contemporary utility. This study evaluated the use and predictive performance of CUE at São João Local Health Unit Blood Bank, Porto – Portugal.
Methods
A retrospective descriptive study assessed all donations with CUE between January 1, 1999 and August 5, 2025. Donor demographics, CUE outcomes, and laboratory results were retrieved. Confirmed reactive serological and nucleic acid testing (NAT) findings were reviewed. The main analytical focus was on findings suggestive of possible window‐period infection after a CUE‐excluded donation. Sensitivity, specificity, and positive predictive value (PPV) were calculated; associations between CUE status and reactivity were assessed with Fisher's exact test and odds ratios (OR) with 95% confidence intervals.
Results
Among 533,227 donations, 2289 (0.429%) underwent CUE self‐exclusion. Twenty‐four (1.05%) showed initially reactive markers at the time of the CUE‐excluded donation or during follow‐up, but none were confirmed as findings suggestive of window‐period infections. CUE demonstrated a sensitivity of 0%, specificity of 0.7%, and PPV of 0%. In the 2009–2025 cohort ( n = 344,666), no reactive results occurred in the CUE group, whereas 149 (0.043%) occurred in the non‐CUE group. No significant association was found between CUE and reactivity ( p = 0.388; OR = 2.045; 95% CI 0.286–14.627).
Discussion
In this retrospective single‐center cohort, CUE showed no measurable diagnostic or predictive value beyond routine screening and identifying possible window‐period infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Immunohemotherapy Department, São João Local Health Unit, Porto, Portugal.
- Department of Community Medicine, Health Information and Decision, University of Porto Faculty of Medicine, Porto, Portugal.
ORCID-Profile: Rita Queirós Pereira
Zitieren
APA
Queirós Pereira, R., Braga, C., Lima Basto, M., Carneiro-Leão, D., Teixeira, S., Nobre Fernandes, S., & Araújo, F. (2026). Confidential unit exclusion (cue): Impact on transfusion safety. Transfusion, 66(8), 1475-1479. https://doi.org/10.1111/trf.70271
Vancouver
Queirós Pereira R, Braga C, Lima Basto M, Carneiro-Leão D, Teixeira S, Nobre Fernandes S, et al. Confidential unit exclusion (cue): Impact on transfusion safety. Transfusion. 2026;66(8):1475-1479. doi:10.1111/trf.70271
BibTeX
@article{QueirsPereira2026,
author = {Queirós Pereira, Rita and Braga, Carlos and Lima Basto, Miguel and Carneiro-Leão, Diana and Teixeira, Sofia and Nobre Fernandes, Susana and Araújo, Fernando},
title = {Confidential unit exclusion (cue): Impact on transfusion safety},
journal = {Transfusion},
year = {2026},
volume = {66},
number = {8},
pages = {1475--1479},
doi = {10.1111/trf.70271}
}
EUVIMED